FI97862B - Menetelmä tetrasykliinikoostumusten valmistamiseksi, joilla on kontrolloitu vapautuminen - Google Patents

Menetelmä tetrasykliinikoostumusten valmistamiseksi, joilla on kontrolloitu vapautuminen

Info

Publication number
FI97862B
FI97862B FI884575A FI884575A FI97862B FI 97862 B FI97862 B FI 97862B FI 884575 A FI884575 A FI 884575A FI 884575 A FI884575 A FI 884575A FI 97862 B FI97862 B FI 97862B
Authority
FI
Finland
Prior art keywords
preparation
controlled release
tetracycline
preparations
tetracycline preparations
Prior art date
Application number
FI884575A
Other languages
English (en)
Swedish (sv)
Other versions
FI884575A (fi
FI884575A0 (fi
FI97862C (fi
Inventor
Jr Joseph J Valorose
Raymond J Biehl
Nitin V Sheth
Walter A Strathy
Michael Kay Doelling
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22303124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI97862(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI884575A0 publication Critical patent/FI884575A0/fi
Publication of FI884575A publication Critical patent/FI884575A/fi
Application granted granted Critical
Publication of FI97862B publication Critical patent/FI97862B/fi
Publication of FI97862C publication Critical patent/FI97862C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI884575A 1987-10-06 1988-10-05 Menetelmä tetrasykliinikoostumusten valmistamiseksi, joilla on kontrolloitu vapautuminen FI97862C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/104,917 US4837030A (en) 1987-10-06 1987-10-06 Novel controlled release formulations of tetracycline compounds
US10491787 1987-10-06

Publications (4)

Publication Number Publication Date
FI884575A0 FI884575A0 (fi) 1988-10-05
FI884575A FI884575A (fi) 1989-04-07
FI97862B true FI97862B (fi) 1996-11-29
FI97862C FI97862C (fi) 1997-03-10

Family

ID=22303124

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884575A FI97862C (fi) 1987-10-06 1988-10-05 Menetelmä tetrasykliinikoostumusten valmistamiseksi, joilla on kontrolloitu vapautuminen

Country Status (24)

Country Link
US (1) US4837030A (fi)
EP (1) EP0310814B1 (fi)
JP (1) JP2771189B2 (fi)
KR (1) KR970007902B1 (fi)
AR (1) AR243077A1 (fi)
AT (1) ATE120957T1 (fi)
AU (1) AU609525B2 (fi)
CA (1) CA1338439C (fi)
CZ (1) CZ279809B6 (fi)
DE (1) DE3853566T2 (fi)
DK (1) DK175578B1 (fi)
ES (1) ES2070837T3 (fi)
FI (1) FI97862C (fi)
GR (1) GR3015767T3 (fi)
HK (1) HK1000313A1 (fi)
HU (1) HU202110B (fi)
IL (1) IL87699A (fi)
NO (1) NO175619C (fi)
NZ (1) NZ226396A (fi)
PH (1) PH27236A (fi)
PL (1) PL275089A1 (fi)
PT (1) PT88664B (fi)
SK (1) SK278567B6 (fi)
ZA (1) ZA887478B (fi)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
ATE108996T1 (de) * 1988-02-25 1994-08-15 Brocades Pharma Bv Verfahren zur herstellung eines pharmazeutischen granulats.
ES2064564T3 (es) * 1989-09-21 1995-02-01 American Cyanamid Co Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
USRE40183E1 (en) 1991-10-04 2008-03-25 Wyeth Holdings Corporation 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
DE69231499T2 (de) * 1991-12-30 2001-05-03 Fmc Corp Zusammensetzung auf der basis von mikrokristalliner zellulose für die herstellung von kugelförmigen teilchen
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
CA2093282C (en) * 1992-05-04 1999-01-12 Tibor Sipos Intraoral medicament-releasing device
US6224911B1 (en) * 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
US5536507A (en) * 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
US20060068017A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US6230052B1 (en) 1999-01-29 2001-05-08 Andy Wolff Device and method for stimulating salivation
WO2000072831A1 (en) * 1999-05-27 2000-12-07 Drugtech Corporation Nutritional formulations
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
US20040115261A1 (en) * 2001-04-05 2004-06-17 Ashley Robert A. Controlled delivery of tetracycline compounds and tetracycline derivatives
EP1455751A1 (en) * 2001-12-20 2004-09-15 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
AU2003213876B2 (en) * 2002-04-12 2006-10-12 Mayne Pharma International Pty Ltd An improved modified release preparation
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
MXPA05004648A (es) * 2002-10-30 2005-06-08 Pharmacia Corp Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos.
US20040158194A1 (en) * 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
EP1615622B1 (en) 2003-04-07 2012-07-11 Supernus Pharmaceuticals, Inc. Once daily formulations of doxycyclines
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
EA012315B1 (ru) * 2005-02-04 2009-08-28 Филип Моррис Продактс С.А. Сигарета и фильтр с ароматизирующей добавкой на основе целлюлозы
US20070106138A1 (en) * 2005-05-26 2007-05-10 Beiski Ben Z Intraoral apparatus for non-invasive blood and saliva monitoring & sensing
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
KR20080080205A (ko) * 2005-12-22 2008-09-02 와이어쓰 티게사이클린을 포함하는 경구 제형
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
JP5527921B2 (ja) * 2006-12-22 2014-06-25 エスエス製薬株式会社 苦味を隠蔽した経口固形組成物
ITMI20070022A1 (it) 2007-01-09 2008-07-10 I P S Internat Products & Services Srl Formulazione di prodotti solidi a rilascio controllato per uso orale in bustine monodose e relativo procedimento di preparazione
CN102688492A (zh) * 2007-03-23 2012-09-26 分子研究中心公司 包含四环素类的抗炎组合物及其用途
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
WO2010017310A1 (en) * 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2013122260A1 (en) * 2012-02-15 2013-08-22 Takeda Pharmaceutical Company Limited Tablet
EA034234B1 (ru) 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
WO2016162754A1 (en) 2015-04-07 2016-10-13 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3356571A (en) * 1964-11-25 1967-12-05 American Cyanamid Co Potentiation of tetracycline by polyacrylic acid or hydrolyzed polyacrylonitrile
CH434571A (de) * 1966-07-05 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
CH434240A (de) * 1965-12-30 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung einer therapeutischen Tetracyclinzubereitung mit verlängerter therapeutischer Wirkung
IT1050353B (it) * 1966-01-06 1981-03-10 Ceskoslovenska Akademie Ved Supporti per sostanze biologigamente attive
US4207258A (en) * 1972-02-24 1980-06-10 Ankerfarm S.P.A. Process for the preparatin of α-6-deoxytetracyclines
FR2183546B1 (fi) * 1972-05-10 1975-06-20 Servier Lab
US4038315A (en) * 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
CH582002A5 (fi) * 1972-06-09 1976-11-30 Purdue Research Foundation
CA999855A (en) * 1972-09-18 1976-11-16 Societa' Farmaceutici Italia S.P.A. Process for the preparation of tetracyclines derivatives in the 7 position
JPS4941522A (fi) * 1973-05-17 1974-04-18
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
US4154827A (en) * 1977-12-15 1979-05-15 University Of Pennsylvania Inhibition of ADH-stimulated osmotic water flow and aldosterone-stimulated sodium transport
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
ES8307096A1 (es) * 1981-06-01 1983-07-01 Orion Yhtymae Oy "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4500458A (en) * 1982-01-19 1985-02-19 Plurichemie Anstalt Process for the preparation of α-6-deoxytetracyclines
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases

Also Published As

Publication number Publication date
PH27236A (en) 1993-05-04
US4837030A (en) 1989-06-06
FI884575A (fi) 1989-04-07
PL275089A1 (en) 1989-07-10
NO175619B (fi) 1994-08-01
AR243077A1 (es) 1993-07-30
ZA887478B (en) 1989-06-28
ES2070837T3 (es) 1995-06-16
JPH01128929A (ja) 1989-05-22
IL87699A0 (en) 1989-02-28
PT88664A (pt) 1989-07-31
DE3853566D1 (de) 1995-05-18
AU2344488A (en) 1989-04-06
HUT50046A (en) 1989-12-28
KR970007902B1 (ko) 1997-05-17
HU202110B (en) 1991-02-28
NO884408D0 (no) 1988-10-05
SK656388A3 (en) 1997-10-08
NZ226396A (en) 1991-08-27
NO884408L (no) 1989-04-07
EP0310814A3 (en) 1989-05-03
ATE120957T1 (de) 1995-04-15
DK556788A (da) 1989-04-07
GR3015767T3 (en) 1995-07-31
CA1338439C (en) 1996-07-09
EP0310814A2 (en) 1989-04-12
AU609525B2 (en) 1991-05-02
FI884575A0 (fi) 1988-10-05
KR890006242A (ko) 1989-06-12
DK175578B1 (da) 2004-12-13
PT88664B (pt) 2003-06-30
NO175619C (no) 1994-11-09
JP2771189B2 (ja) 1998-07-02
DE3853566T2 (de) 1996-01-11
CZ279809B6 (cs) 1995-07-12
CZ656388A3 (en) 1995-02-15
EP0310814B1 (en) 1995-04-12
SK278567B6 (en) 1997-10-08
IL87699A (en) 1994-06-24
FI97862C (fi) 1997-03-10
DK556788D0 (da) 1988-10-05
HK1000313A1 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
FI97862B (fi) Menetelmä tetrasykliinikoostumusten valmistamiseksi, joilla on kontrolloitu vapautuminen
NO872966D0 (no) Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
ES2021699B3 (es) Proceso para la preparacion de esteres.
NO173498C (no) Analogifremgangsmaate for fremstilling av substituerte 9-amino-tetrahydroakridiner
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO880262D0 (no) Fremgangsmaate for fremstilling av b avermectiner.
FI892058A0 (fi) Fenolin valmistusmenetelmä
NO881602L (no) Fremgangsmaate for fremstilling av keramiske superlederfilamenter.
FI881303A0 (fi) Menetelmä ibuprofeenin valmistamiseksi
NO883813D0 (no) Fremgangsmaate for fremstilling av homopolyamider.
IT1218065B (it) Procedimento per pa preparazione di 1,2,5,6,9,10 esabromociclododecano
NO885002L (no) Fremgangsmaate for fremstilling av sialocylglycerolipider.
NO882730L (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
FI93423C (fi) Menetelmä rokotteen valmistamiseksi
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert
NO885446D0 (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrer.
FI93008B (fi) Menetelmä bakteerien vastaisten 6-fluori-1,4-dihydrokinol-4-oni-3-karboksyylihappojohdannaisten valmistamiseksi
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
NO880834D0 (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO880106D0 (no) Fremgangsmaate til fremstilling av kalknitrogen.
FI102370B1 (fi) Menetelmä N-metyyli-3,4-dimetoksifenyylietyyliamiinin valmistamiseksi
NO880844L (no) Fremgangsmaate for fremstilling av cytotoksiner.
NO890375D0 (no) Fremgangsmaate for fremstilling av heksanitrostilben.
SE8801744D0 (sv) Forfarande for framstellning av ditionit
NO913089L (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: WYETH HOLDINGS CORPORATION

MA Patent expired